Kolexia
Quesada Stanislas Oncologie médicale
Quesada Stanislas
Oncologie médicale
Institut régional du cancer de Montpellier
Lieu inconnu
93 Activités
5.2 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Carcinome épithélial de l'ovaire Tumeurs du sein Carcinomes Adénocarcinome Tumeurs de l'oesophage Alopécie Tumeurs de l'estomac Cholangiocarcinome

Collaborateurs

Voir plus
Fiteni Frederic
Fiteni Frederic
Hôpital Carémeau, Nîmes, France
Ray Isabelle
Ray Isabelle
Centre Léon-Bérard, Lyon, France
Fabbro Michel
Fabbro Michel
Icm Montpellier, Montpellier, France
Tredan Olivier
Tredan Olivier
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Amgen
4 collaboration(s)
Dernière en 2021
AstraZeneca
3 collaboration(s)
Dernière en 2022
GSK
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Ivosidenib in the treatment of patients with cholangiocarcinoma with an IDH1 R132 mutation who were previously treated by at least one prior line of systemic therapy.
Bulletin du cancer   11 septembre 2023
The quest for the optimal biomarker: is extending the spectrum of targeted mutations in breast cancer carcinoma worthwhile?
Annals of translational medicine   29 août 2023
Optimal First-Line Medico-Surgical Strategy in Ovarian Cancers: Are We There Yet?
Cancers   10 juillet 2023
Tertiary lymphoid structures in cancer: From biology to therapeutic guides.
Bulletin du cancer   05 mai 2023
Combination strategies for checkpoint inhibition: Current practices and perspectives.
Bulletin du cancer   11 avril 2023
Treatments for rare ovarian tumors: What's new?.
Bulletin du cancer   10 avril 2023
Homologous recombination deficiency in epithelial ovarian cancers: from molecular characterization to patient journey.
Bulletin du cancer   28 février 2023
Update on new treatments for rare ovarian tumours.
Current opinion in obstetrics & gynecology   18 novembre 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial.
Journal of personalized medicine   27 septembre 2022
Real-World Data on Newly Diagnosed -Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database.
Cancers   21 août 2022